APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plaque Psoriasis Treatment Medications

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plaque Psoriasis Treatment Medications Market Analysis and Forecast 2026-2032

29 December 2025202 pages

Choose your research edition.

Industry ResearchPlaque Psoriasis Treatment Medications Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Plaque Psoriasis Treatment Medications Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Plaque Psoriasis Treatment Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plaque Psoriasis Treatment Medications Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Plaque Psoriasis Treatment Medications Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Plaque Psoriasis Treatment Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Plaque Psoriasis Treatment Medications include Johnson & Johnson, Novartis, Merck, Eli Lilly, Pfizer, UCB, Organon, LEO Pharma and Galectin Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Plaque Psoriasis Treatment Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plaque Psoriasis Treatment Medications, also provides the sales of main regions and countries. Of the upcoming market potential for Plaque Psoriasis Treatment Medications, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plaque Psoriasis Treatment Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plaque Psoriasis Treatment Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Plaque Psoriasis Treatment Medications sales, projected growth trends, production technology, application and end-user industry.

Plaque Psoriasis Treatment Medications Segment by Company

Johnson & Johnson

Novartis

Merck

Eli Lilly

Pfizer

UCB

Organon

LEO Pharma

Galectin Therapeutics

Dermira

Cellceutix

Biogen

Bayer

AstraZeneca

Amgen

Allergan

AbbVie

Plaque Psoriasis Treatment Medications Segment by Type

Non-biologic Drugs

Biologics

Small Molecule Drugs

Plaque Psoriasis Treatment Medications Segment by Application

Hospital

Clinic

Other

Plaque Psoriasis Treatment Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plaque Psoriasis Treatment Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plaque Psoriasis Treatment Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plaque Psoriasis Treatment Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Plaque Psoriasis Treatment Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plaque Psoriasis Treatment Medications sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-biologic Drugs Major Manufacturers Table 3. Biologics Major Manufacturers Table 4. Small Molecule Drugs Major Manufacturers Table 5. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Plaque Psoriasis Treatment Medications Industry Trends Table 10. Plaque Psoriasis Treatment Medications Industry Drivers Table 11. Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges Table 12. Plaque Psoriasis Treatment Medications Industry Restraints Table 13. Global Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Plaque Psoriasis Treatment Medications Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Plaque Psoriasis Treatment Medications Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021-2026) Table 17. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2027-2032) Table 18. Global Plaque Psoriasis Treatment Medications Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2026) & (K Units) Table 20. Global Plaque Psoriasis Treatment Medications Sales by Region (2027-2032) & (K Units) Table 21. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021-2026) Table 22. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2027-2032) Table 23. Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2021-2026) Table 27. Global Plaque Psoriasis Treatment Medications Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Plaque Psoriasis Treatment Medications Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Plaque Psoriasis Treatment Medications Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Plaque Psoriasis Treatment Medications Manufacturers, Product Type & Application Table 31. Global Plaque Psoriasis Treatment Medications Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Plaque Psoriasis Treatment Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Plaque Psoriasis Treatment Medications Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2026) Table 38. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2027-2032) Table 39. Global Plaque Psoriasis Treatment Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 41. Global Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 42. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2026) Table 43. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2027-2032) Table 44. Global Plaque Psoriasis Treatment Medications Price by Type (2021-2026) & (US$/Unit) Table 45. Global Plaque Psoriasis Treatment Medications Price by Type (2027-2032) & (US$/Unit) Table 46. Global Plaque Psoriasis Treatment Medications Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2026) Table 50. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2027-2032) Table 51. Global Plaque Psoriasis Treatment Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 53. Global Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 54. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2026) Table 55. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2027-2032) Table 56. Global Plaque Psoriasis Treatment Medications Price by Application (2021-2026) & (US$/Unit) Table 57. Global Plaque Psoriasis Treatment Medications Price by Application (2027-2032) & (US$/Unit) Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Novartis Plaque Psoriasis Treatment Medications Product Portfolio Table 67. Novartis Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck Plaque Psoriasis Treatment Medications Product Portfolio Table 72. Merck Recent Development Table 73. Eli Lilly Company Information Table 74. Eli Lilly Business Overview Table 75. Eli Lilly Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio Table 77. Eli Lilly Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Plaque Psoriasis Treatment Medications Product Portfolio Table 82. Pfizer Recent Development Table 83. UCB Company Information Table 84. UCB Business Overview Table 85. UCB Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. UCB Plaque Psoriasis Treatment Medications Product Portfolio Table 87. UCB Recent Development Table 88. Organon Company Information Table 89. Organon Business Overview Table 90. Organon Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Organon Plaque Psoriasis Treatment Medications Product Portfolio Table 92. Organon Recent Development Table 93. LEO Pharma Company Information Table 94. LEO Pharma Business Overview Table 95. LEO Pharma Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio Table 97. LEO Pharma Recent Development Table 98. Galectin Therapeutics Company Information Table 99. Galectin Therapeutics Business Overview Table 100. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio Table 102. Galectin Therapeutics Recent Development Table 103. Dermira Company Information Table 104. Dermira Business Overview Table 105. Dermira Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Dermira Plaque Psoriasis Treatment Medications Product Portfolio Table 107. Dermira Recent Development Table 108. Cellceutix Company Information Table 109. Cellceutix Business Overview Table 110. Cellceutix Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio Table 112. Cellceutix Recent Development Table 113. Biogen Company Information Table 114. Biogen Business Overview Table 115. Biogen Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Biogen Plaque Psoriasis Treatment Medications Product Portfolio Table 117. Biogen Recent Development Table 118. Bayer Company Information Table 119. Bayer Business Overview Table 120. Bayer Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Bayer Plaque Psoriasis Treatment Medications Product Portfolio Table 122. Bayer Recent Development Table 123. AstraZeneca Company Information Table 124. AstraZeneca Business Overview Table 125. AstraZeneca Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio Table 127. AstraZeneca Recent Development Table 128. Amgen Company Information Table 129. Amgen Business Overview Table 130. Amgen Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Amgen Plaque Psoriasis Treatment Medications Product Portfolio Table 132. Amgen Recent Development Table 133. Allergan Company Information Table 134. Allergan Business Overview Table 135. Allergan Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Allergan Plaque Psoriasis Treatment Medications Product Portfolio Table 137. Allergan Recent Development Table 138. AbbVie Company Information Table 139. AbbVie Business Overview Table 140. AbbVie Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. AbbVie Plaque Psoriasis Treatment Medications Product Portfolio Table 142. AbbVie Recent Development Table 143. North America Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 146. North America Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 147. North America Plaque Psoriasis Treatment Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 148. North America Plaque Psoriasis Treatment Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 149. North America Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 152. North America Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 153. North America Plaque Psoriasis Treatment Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 154. North America Plaque Psoriasis Treatment Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 155. North America Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. North America Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 160. North America Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 161. North America Plaque Psoriasis Treatment Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 162. North America Plaque Psoriasis Treatment Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 163. United States Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 164. Canada Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 165. Mexico Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 166. Europe Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 169. Europe Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 170. Europe Plaque Psoriasis Treatment Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 171. Europe Plaque Psoriasis Treatment Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 172. Europe Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 175. Europe Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 176. Europe Plaque Psoriasis Treatment Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 177. Europe Plaque Psoriasis Treatment Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Europe Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 182. Europe Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 183. Europe Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 184. Europe Plaque Psoriasis Treatment Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 185. Europe Plaque Psoriasis Treatment Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Germany Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 187. France Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 188. U.K. Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 189. Italy Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 190. Russia Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 191. Spain Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 193. Switzerland Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 194. Sweden Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 195. Poland Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 196. China Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 197. China Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 198. China Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 199. China Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 200. China Plaque Psoriasis Treatment Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 201. China Plaque Psoriasis Treatment Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 202. China Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 203. China Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 204. China Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 205. China Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 206. China Plaque Psoriasis Treatment Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 207. China Plaque Psoriasis Treatment Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 208. Asia Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 211. Asia Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 212. Asia Plaque Psoriasis Treatment Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 213. Asia Plaque Psoriasis Treatment Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 214. Asia Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 215. Asia Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 216. Asia Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 217. Asia Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 218. Asia Plaque Psoriasis Treatment Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 219. Asia Plaque Psoriasis Treatment Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 220. Asia Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. Asia Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. Asia Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. Asia Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. Asia Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 225. Asia Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 226. Asia Plaque Psoriasis Treatment Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 227. Asia Plaque Psoriasis Treatment Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Japan Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 229. South Korea Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 230. India Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 231. Australia Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 232. Taiwan Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 233. Southeast Asia Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 234. SAMEA Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 235. SAMEA Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 236. SAMEA Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 237. SAMEA Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 238. SAMEA Plaque Psoriasis Treatment Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 239. SAMEA Plaque Psoriasis Treatment Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 240. SAMEA Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 241. SAMEA Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 242. SAMEA Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 243. SAMEA Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 244. SAMEA Plaque Psoriasis Treatment Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 245. SAMEA Plaque Psoriasis Treatment Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 246. SAMEA Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. SAMEA Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. SAMEA Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 250. SAMEA Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 251. SAMEA Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 252. SAMEA Plaque Psoriasis Treatment Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 253. SAMEA Plaque Psoriasis Treatment Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 254. Brazil Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 255. Argentina Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 256. Chile Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 257. Colombia Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 258. Peru Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 259. Saudi Arabia Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 260. Israel Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 261. UAE Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 262. Turkey Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 263. Iran Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 264. Egypt Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Table 265. Key Raw Materials Table 266. Raw Materials Key Suppliers Table 267. Plaque Psoriasis Treatment Medications Distributors List Table 268. Plaque Psoriasis Treatment Medications Customers List Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Plaque Psoriasis Treatment Medications Image Figure 2. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plaque Psoriasis Treatment Medications Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-biologic Drugs Image Figure 5. Biologics Image Figure 6. Small Molecule Drugs Image Figure 7. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Plaque Psoriasis Treatment Medications Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Figure 14. Global Plaque Psoriasis Treatment Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021-2032) Figure 17. Global Plaque Psoriasis Treatment Medications Sales (2021-2032) & (K Units) Figure 18. Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Plaque Psoriasis Treatment Medications Sales YoY (2021-2032) & (K Units) Figure 21. Europe Plaque Psoriasis Treatment Medications Sales YoY (2021-2032) & (K Units) Figure 22. China Plaque Psoriasis Treatment Medications Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Plaque Psoriasis Treatment Medications Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales YoY (2021-2032) & (K Units) Figure 25. Global Plaque Psoriasis Treatment Medications Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Plaque Psoriasis Treatment Medications Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Plaque Psoriasis Treatment Medications Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2032) Figure 31. Global Plaque Psoriasis Treatment Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2032) Figure 34. Global Plaque Psoriasis Treatment Medications Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032) Figure 37. Global Plaque Psoriasis Treatment Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2032) Figure 40. North America Plaque Psoriasis Treatment Medications Revenue Share by Type (2021-2032) Figure 41. North America Plaque Psoriasis Treatment Medications Sales Share by Type (2021-2032) Figure 42. North America Plaque Psoriasis Treatment Medications Revenue Share by Application (2021-2032) Figure 43. North America Plaque Psoriasis Treatment Medications Sales Share by Application (2021-2032) Figure 44. North America Plaque Psoriasis Treatment Medications Revenue Share by Country (2021-2032) Figure 45. North America Plaque Psoriasis Treatment Medications Sales Share by Country (2021-2032) Figure 46. Europe Plaque Psoriasis Treatment Medications Revenue Share by Type (2021-2032) Figure 47. Europe Plaque Psoriasis Treatment Medications Sales Share by Type (2021-2032) Figure 48. Europe Plaque Psoriasis Treatment Medications Revenue Share by Application (2021-2032) Figure 49. Europe Plaque Psoriasis Treatment Medications Sales Share by Application (2021-2032) Figure 50. Europe Plaque Psoriasis Treatment Medications Revenue Share by Country (2021-2032) Figure 51. Europe Plaque Psoriasis Treatment Medications Sales Share by Country (2021-2032) Figure 52. China Plaque Psoriasis Treatment Medications Revenue Share by Type (2021-2032) Figure 53. China Plaque Psoriasis Treatment Medications Sales Share by Type (2021-2032) Figure 54. China Plaque Psoriasis Treatment Medications Revenue Share by Application (2021-2032) Figure 55. China Plaque Psoriasis Treatment Medications Sales Share by Application (2021-2032) Figure 56. Asia Plaque Psoriasis Treatment Medications Revenue Share by Type (2021-2032) Figure 57. Asia Plaque Psoriasis Treatment Medications Sales Share by Type (2021-2032) Figure 58. Asia Plaque Psoriasis Treatment Medications Revenue Share by Application (2021-2032) Figure 59. Asia Plaque Psoriasis Treatment Medications Sales Share by Application (2021-2032) Figure 60. Asia Plaque Psoriasis Treatment Medications Revenue Share by Country (2021-2032) Figure 61. Asia Plaque Psoriasis Treatment Medications Sales Share by Country (2021-2032) Figure 62. SAMEA Plaque Psoriasis Treatment Medications Revenue Share by Type (2021-2032) Figure 63. SAMEA Plaque Psoriasis Treatment Medications Sales Share by Type (2021-2032) Figure 64. SAMEA Plaque Psoriasis Treatment Medications Revenue Share by Application (2021-2032) Figure 65. SAMEA Plaque Psoriasis Treatment Medications Sales Share by Application (2021-2032) Figure 66. SAMEA Plaque Psoriasis Treatment Medications Revenue Share by Country (2021-2032) Figure 67. SAMEA Plaque Psoriasis Treatment Medications Sales Share by Country (2021-2032) Figure 68. Plaque Psoriasis Treatment Medications Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Plaque Psoriasis Treatment Medications Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biologic Drugs
  • Biologics
  • Small Molecule Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • UCB
  • Organon
  • LEO Pharma
  • Galectin Therapeutics
  • Dermira
  • Cellceutix
  • Biogen
  • Bayer
  • AstraZeneca
  • Amgen
  • Allergan
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plaque Psoriasis Treatment Medications Market by Type
  3. 1.2.1 Global Plaque Psoriasis Treatment Medications Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-biologic Drugs
  5. 1.2.3 Biologics
  6. 1.2.4 Small Molecule Drugs
  7. 1.3 Plaque Psoriasis Treatment Medications Market by Application
  8. 1.3.1 Global Plaque Psoriasis Treatment Medications Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Plaque Psoriasis Treatment Medications Market Dynamics
  1. 2.1 Plaque Psoriasis Treatment Medications Industry Trends
  2. 2.2 Plaque Psoriasis Treatment Medications Industry Drivers
  3. 2.3 Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges
  4. 2.4 Plaque Psoriasis Treatment Medications Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Plaque Psoriasis Treatment Medications Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Plaque Psoriasis Treatment Medications Revenue by Region
  3. 3.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plaque Psoriasis Treatment Medications Revenue by Region (2021-2026)
  5. 3.2.3 Global Plaque Psoriasis Treatment Medications Revenue by Region (2027-2032)
  6. 3.2.4 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Plaque Psoriasis Treatment Medications Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Plaque Psoriasis Treatment Medications Sales by Region
  9. 3.4.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2026)
  11. 3.4.3 Global Plaque Psoriasis Treatment Medications Sales by Region (2027-2032)
  12. 3.4.4 Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers
  2. 4.1.1 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Plaque Psoriasis Treatment Medications Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers
  6. 4.2.1 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Plaque Psoriasis Treatment Medications Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Plaque Psoriasis Treatment Medications Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Plaque Psoriasis Treatment Medications Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Plaque Psoriasis Treatment Medications Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Plaque Psoriasis Treatment Medications Manufacturers, Product Type & Application
  13. 4.7 Global Plaque Psoriasis Treatment Medications Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Plaque Psoriasis Treatment Medications Market CR5 and HHI
  16. 4.8.2 2025 Plaque Psoriasis Treatment Medications Tier 1, Tier 2, and Tier 3
5 Plaque Psoriasis Treatment Medications Market by Type
  1. 5.1 Global Plaque Psoriasis Treatment Medications Revenue by Type
  2. 5.1.1 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Plaque Psoriasis Treatment Medications Sales by Type
  6. 5.2.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2032)
  9. 5.3 Global Plaque Psoriasis Treatment Medications Price by Type
6 Plaque Psoriasis Treatment Medications Market by Application
  1. 6.1 Global Plaque Psoriasis Treatment Medications Revenue by Application
  2. 6.1.1 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Plaque Psoriasis Treatment Medications Sales by Application
  6. 6.2.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2032)
  9. 6.3 Global Plaque Psoriasis Treatment Medications Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Plaque Psoriasis Treatment Medications Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Plaque Psoriasis Treatment Medications Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Eli Lilly
  20. 7.4.1 Eli Lilly Company Information
  21. 7.4.2 Eli Lilly Business Overview
  22. 7.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio
  24. 7.4.5 Eli Lilly Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Plaque Psoriasis Treatment Medications Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 UCB
  32. 7.6.1 UCB Company Information
  33. 7.6.2 UCB Business Overview
  34. 7.6.3 UCB Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 UCB Plaque Psoriasis Treatment Medications Product Portfolio
  36. 7.6.5 UCB Recent Developments
  37. 7.7 Organon
  38. 7.7.1 Organon Company Information
  39. 7.7.2 Organon Business Overview
  40. 7.7.3 Organon Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Organon Plaque Psoriasis Treatment Medications Product Portfolio
  42. 7.7.5 Organon Recent Developments
  43. 7.8 LEO Pharma
  44. 7.8.1 LEO Pharma Company Information
  45. 7.8.2 LEO Pharma Business Overview
  46. 7.8.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio
  48. 7.8.5 LEO Pharma Recent Developments
  49. 7.9 Galectin Therapeutics
  50. 7.9.1 Galectin Therapeutics Company Information
  51. 7.9.2 Galectin Therapeutics Business Overview
  52. 7.9.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio
  54. 7.9.5 Galectin Therapeutics Recent Developments
  55. 7.10 Dermira
  56. 7.10.1 Dermira Company Information
  57. 7.10.2 Dermira Business Overview
  58. 7.10.3 Dermira Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Dermira Plaque Psoriasis Treatment Medications Product Portfolio
  60. 7.10.5 Dermira Recent Developments
  61. 7.11 Cellceutix
  62. 7.11.1 Cellceutix Company Information
  63. 7.11.2 Cellceutix Business Overview
  64. 7.11.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio
  66. 7.11.5 Cellceutix Recent Developments
  67. 7.12 Biogen
  68. 7.12.1 Biogen Company Information
  69. 7.12.2 Biogen Business Overview
  70. 7.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Biogen Plaque Psoriasis Treatment Medications Product Portfolio
  72. 7.12.5 Biogen Recent Developments
  73. 7.13 Bayer
  74. 7.13.1 Bayer Company Information
  75. 7.13.2 Bayer Business Overview
  76. 7.13.3 Bayer Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bayer Plaque Psoriasis Treatment Medications Product Portfolio
  78. 7.13.5 Bayer Recent Developments
  79. 7.14 AstraZeneca
  80. 7.14.1 AstraZeneca Company Information
  81. 7.14.2 AstraZeneca Business Overview
  82. 7.14.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio
  84. 7.14.5 AstraZeneca Recent Developments
  85. 7.15 Amgen
  86. 7.15.1 Amgen Company Information
  87. 7.15.2 Amgen Business Overview
  88. 7.15.3 Amgen Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Amgen Plaque Psoriasis Treatment Medications Product Portfolio
  90. 7.15.5 Amgen Recent Developments
  91. 7.16 Allergan
  92. 7.16.1 Allergan Company Information
  93. 7.16.2 Allergan Business Overview
  94. 7.16.3 Allergan Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Allergan Plaque Psoriasis Treatment Medications Product Portfolio
  96. 7.16.5 Allergan Recent Developments
  97. 7.17 AbbVie
  98. 7.17.1 AbbVie Company Information
  99. 7.17.2 AbbVie Business Overview
  100. 7.17.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 AbbVie Plaque Psoriasis Treatment Medications Product Portfolio
  102. 7.17.5 AbbVie Recent Developments
8 North America
  1. 8.1 North America Plaque Psoriasis Treatment Medications Market Size by Type
  2. 8.1.1 North America Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  3. 8.1.2 North America Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  4. 8.1.3 North America Plaque Psoriasis Treatment Medications Price by Type (2021-2032)
  5. 8.2 North America Plaque Psoriasis Treatment Medications Market Size by Application
  6. 8.2.1 North America Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  7. 8.2.2 North America Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  8. 8.2.3 North America Plaque Psoriasis Treatment Medications Price by Application (2021-2032)
  9. 8.3 North America Plaque Psoriasis Treatment Medications Market Size by Country
  10. 8.3.1 North America Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Plaque Psoriasis Treatment Medications Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Plaque Psoriasis Treatment Medications Market Size by Type
  2. 9.1.1 Europe Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  3. 9.1.2 Europe Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  4. 9.1.3 Europe Plaque Psoriasis Treatment Medications Price by Type (2021-2032)
  5. 9.2 Europe Plaque Psoriasis Treatment Medications Market Size by Application
  6. 9.2.1 Europe Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  7. 9.2.2 Europe Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  8. 9.2.3 Europe Plaque Psoriasis Treatment Medications Price by Application (2021-2032)
  9. 9.3 Europe Plaque Psoriasis Treatment Medications Market Size by Country
  10. 9.3.1 Europe Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Plaque Psoriasis Treatment Medications Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Plaque Psoriasis Treatment Medications Market Size by Type
  2. 10.1.1 China Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  3. 10.1.2 China Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  4. 10.1.3 China Plaque Psoriasis Treatment Medications Price by Type (2021-2032)
  5. 10.2 China Plaque Psoriasis Treatment Medications Market Size by Application
  6. 10.2.1 China Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  7. 10.2.2 China Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  8. 10.2.3 China Plaque Psoriasis Treatment Medications Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plaque Psoriasis Treatment Medications Market Size by Type
  2. 11.1.1 Asia Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  3. 11.1.2 Asia Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  4. 11.1.3 Asia Plaque Psoriasis Treatment Medications Price by Type (2021-2032)
  5. 11.2 Asia Plaque Psoriasis Treatment Medications Market Size by Application
  6. 11.2.1 Asia Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  7. 11.2.2 Asia Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  8. 11.2.3 Asia Plaque Psoriasis Treatment Medications Price by Application (2021-2032)
  9. 11.3 Asia Plaque Psoriasis Treatment Medications Market Size by Country
  10. 11.3.1 Asia Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Plaque Psoriasis Treatment Medications Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plaque Psoriasis Treatment Medications Market Size by Type
  2. 12.1.1 SAMEA Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Plaque Psoriasis Treatment Medications Price by Type (2021-2032)
  5. 12.2 SAMEA Plaque Psoriasis Treatment Medications Market Size by Application
  6. 12.2.1 SAMEA Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Plaque Psoriasis Treatment Medications Price by Application (2021-2032)
  9. 12.3 SAMEA Plaque Psoriasis Treatment Medications Market Size by Country
  10. 12.3.1 SAMEA Plaque Psoriasis Treatment Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Plaque Psoriasis Treatment Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Plaque Psoriasis Treatment Medications Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Plaque Psoriasis Treatment Medications Value Chain Analysis
  2. 13.1.1 Plaque Psoriasis Treatment Medications Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Plaque Psoriasis Treatment Medications Production Mode & Process
  6. 13.2 Plaque Psoriasis Treatment Medications Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Plaque Psoriasis Treatment Medications Distributors
  9. 13.2.3 Plaque Psoriasis Treatment Medications Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst